Ticker: CBPO, Company: China Biologic Products, Inc., Type: S-3, Date: 2012-07-11
Original SEC Filing: Click here

---

Webplus: CBPO/20120711/S-3/1/000.htm SEC Original: forms3.htm
Registration No. 333- ____________________________ FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CHINA BIOLOGIC PRODUCTS, INC. Delaware 75-2308816 (State or other jurisdiction of incorporation (I.R.S. Employer or organization) Identification No.) 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China +8610-6598-3111 ____________________________ Corporation Service Company 2711 Centerville Road, Suite 400 Wilmington,

---

---

Webplus: CBPO/20120711/S-3/2_EX-4.3/000.htm SEC Original: exhibit4-3.htm
Letter of Undertaking To: Madrone Partners, LP June 6, 2012 Dear Sirs: Holder Company Very truly yours, China Biologic Products, Inc. Ming Yang Interim Chief Financial Officer & Compliance Officer

---

---

Webplus: CBPO/20120711/S-3/3_EX-4.4/000.htm SEC Original: exhibit4-4.htm
Letter of Undertaking To: Essence International Investment Limited June 6, 2012 Dear Sirs: Holder Company Very truly yours, China Biologic Products, Inc. Ming Yang Interim Chief Financial Officer & Compliance Officer

---

---

Webplus: CBPO/20120711/S-3/4_EX-5.1/000.htm SEC Original: exhibit5-1.htm
July 11, 2012 China Biologic Products, Inc. Re: Registration Statement on Form S-3 Ladies and Gentlemen: Based upon the foregoing, and subject to the qualifications set forth below, we are of the opinion that the Shares are validly issued, fully paid and non-assessable. * * * Very truly yours, WILSON SONSINI GOODRICH & ROSATI

---

---

Webplus: CBPO/20120711/S-3/5_EX-23.1/000.htm SEC Original: exhibit23-1.htm
Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the use of our reports dated March 12, 2012, with respect to the consolidated balance sheets of China Biologic Products, Inc. as of December 31, 2011 and 2010, and the related consolidated statements of comprehensive income, changes in equity, and cash flows for each of the

---

---

Webplus: CBPO/20120711/S-3/6_EX-23.2/000.htm SEC Original: exhibit23-2.htm
Consent of Independent Registered Public Accounting Firm To the Board of Directors of We consent to the incorporation by reference in this Registration Statement on Form S-3 of our report dated March 23, 2010, except for the effects on the consolidated financial statements of the restatement described in Note 2, as to which the date is March 31, 2011, with

---

Company Information:

Ticker: CBPO, Company: China Biologic Products, Inc., Type: S-3, Date: 2012-07-11CIK: 0001369868, Location: F4, SIC: 2836, SIC Desc: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Phone & Address:
18TH FL, JIALONG INTERNATIONALBUILDING
BEIJING 100125